TP53 and cancer: GSEA showed that the high-risk group was more enriched in cancer-related pathways, such as the p53 pathway and mitogen-activated protein kinase pathway, whereas the low-risk group was more enriched in metabolism-related pathways, which explained (at least in part) the worse prognosis of the high-risk group.